Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6.David Andorsky, Jeff P. Sharman, Bradley W. Lash et al.|Journal of Clinical Oncology|2024Cited by 2